A synthetic hexapeptide that pioneered the GHRP (Growth Hormone Releasing Peptide) class — studied for potent, reliable GH secretion stimulation and its foundational role in discovering the ghrelin receptor.
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide (6 amino acids) that was one of the first compounds developed to stimulate growth hormone release by a mechanism distinct from GHRH. Discovered in the 1980s by Cyril Bowers at Tulane University, GHRP-6 represented a major breakthrough in understanding GH secretion — it proved that there was a second, independent pathway for stimulating the pituitary to release GH, separate from the GHRH receptor pathway. This discovery ultimately led to the identification of ghrelin (the "hunger hormone") and the characterization of the ghrelin receptor (GHS-R1a) — a major contribution to endocrinology.
GHRP-6 is a "dirty" GHRP compared to more selective later compounds like Ipamorelin — meaning it produces strong GH release but also activates off-target pathways, causing notable cortisol elevation, prolactin elevation, and pronounced appetite stimulation. These properties actually make it useful as a research tool for studying the full spectrum of ghrelin receptor activation, including appetite regulation.
As the first widely studied GHRP, GHRP-6 remains a reference compound for the entire class.
📡 Weekly peptide research updates — regulatory updates, new compound profiles, COA alerts.
⚠️ FDA PCAC: -- days leftNo spam. Unsubscribe anytime. 7 peptides under review — see what's at stake →
7 free research tools built around exactly this kind of compound data. No paywall, no credit card.
GHRP-6 binds to the ghrelin receptor (GHS-R1a) on somatotroph cells in the anterior pituitary, triggering a signaling cascade that results in GH exocytosis. Unlike GHRH-based peptides (like CJC-1295 or Sermorelin), GHRP-6 works through a completely separate receptor and signaling pathway — but the end result of GH release is the same, and the two pathways are synergistic when combined.
GHRP-6 also activates GHS-R1a in the hypothalamus, where it amplifies the natural GHRH signal and suppresses somatostatin (the hormone that inhibits GH release), creating a dual-action amplification of GH output. The appetite stimulation comes from GHS-R1a activation in the hypothalamic arcuate nucleus, where ghrelin receptor signaling drives hunger signals — GHRP-6 activates this pathway as a side effect of binding the same receptor.
Think of the pituitary GH release system as a locked room with two different keys. GHRH (mimicked by CJC-1295 and Sermorelin) uses the first key (GHRH receptor). GHRP-6 uses the second key (ghrelin receptor). Both open the door and release GH. Use both keys simultaneously and the door opens much wider. GHRP-6's extra "side effects" are because the ghrelin receptor is also found in other rooms (hypothalamus, heart) — and GHRP-6 doesn't have the precision to open only the pituitary door.
Research Disclaimer: The following reflects published clinical and preclinical research and is not medical advice. Consult a licensed healthcare provider before making any health decisions.
GHRP-6 was extensively studied in human subjects in the 1990s as the original GHRP — its clinical pharmacology profile is well-established in the published literature.
Key References: Bowers CY et al. (1991). GHRP-6 in humans. J Clin Endocrinol Metab. · Jaffe CA et al. (1993). GHRH + GHRP-6 synergism. J Clin Endocrinol Metab. · Bowers CY (1998). GHRP history review. J Pediatr Endocrinol Metab.
GHRP-6 is the compound that indirectly led to the 1999 discovery of ghrelin — the hunger hormone. Researchers knew GHRP-6 bound a receptor in the pituitary and hypothalamus, and they went looking for the natural hormone that used that receptor. What they found was ghrelin. So a synthetic peptide preceded and enabled the discovery of its own natural analog.
Cyril Bowers, who developed GHRP-6, spent decades systematically modifying the enkephalin peptide structure (yes, related to endorphins) looking for molecules that stimulate GH. The GHRP class emerged from that painstaking chemical modification work — an example of how random-seeming peptide design sometimes stumbles into something important.
GHRP-6 has one of the most pronounced appetite-stimulating effects of any research peptide — subjects in research trials consistently report intense hunger after administration. This made it less useful clinically but more useful for studying the ghrelin receptor's role in appetite regulation specifically.
Every batch of GHRP-6 with full Certificate of Analysis documentation. Third-party HPLC verification, mass spectrometry confirmation, and sterility testing results are included with each batch.